cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Mind Medicine Mindmed Inc
47 own
76 watching
Current Price
$3.44
$0.03
(0.88%)
logo-mnmd
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
129.14M
52-Week High
52-Week High
22.2
52-Week Low
52-Week Low
2.12
Average Volume
Average Volume
0.46M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization129.14M
icon52-Week High22.2
icon52-Week Low2.12
iconAverage Volume0.46M
iconDividend Yield--
iconP/E Ratio--
What does the Mind Medicine Mindmed Inc do?
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.
Read More
How much money does Mind Medicine Mindmed Inc make?
News & Events about Mind Medicine Mindmed Inc.
PR Newswire
21days ago
MindMed Provides Corporate Update and 2023 Outlook MindMed Provides Corporate Update and 2023 Outlook PR Newswire NEW YORK, Jan. 9, 2023 - Company positioned for key MM-120 Phase 2b data readout in GAD and Phase 2a data readout in ADHD in late 2023 - Company to initiate first clinical trial...
CNW Group - News Releases
21days ago
MindMed Provides Corporate Update and 2023 Outlook MindMed Provides Corporate Update and 2023 Outlook Canada NewsWire NEW YORK, Jan. 9, 2023 - Company positioned for key MM-120 Phase 2b data readout in GAD and Phase 2a data readout in ADHD in late 2023 - Company to initiate first clinical trial...
PR Newswire
2 months ago
MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference PR Newswire NEW YORK, Dec. 1, 2022 NEW YORK, Dec. 1, 2022...
CNW Group - News Releases
2 months ago
MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference Canada NewsWire NEW YORK, Dec. 1, 2022 NEW YORK, Dec. 1, 2022 /CNW...
PR Newswire
2 months ago
MindMed to Participate in the Jefferies London Healthcare Conference MindMed to Participate in the Jefferies London Healthcare Conference PR Newswire NEW YORK, Nov. 11, 2022 NEW YORK, Nov. 11, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the 'Company' or...
Frequently Asked Questions
Frequently Asked Questions
What is Mind Medicine Mindmed Inc share price today?
plus_minus_icon
Can Indians buy Mind Medicine Mindmed Inc shares?
plus_minus_icon
How can I buy Mind Medicine Mindmed Inc shares from India?
plus_minus_icon
Can Fractional shares of Mind Medicine Mindmed Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Mind Medicine Mindmed Inc stocks?
plus_minus_icon
What is today’s traded volume of Mind Medicine Mindmed Inc?
plus_minus_icon
What is today’s market capitalisation of Mind Medicine Mindmed Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Mind Medicine Mindmed Inc?
plus_minus_icon
What percentage is Mind Medicine Mindmed Inc down from its 52-Week High?
plus_minus_icon
What percentage is Mind Medicine Mindmed Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.44
$0.03
(0.88%)
logo-mnmd
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00